Tevogen Bio Holdings Inc.
TVGN
$0.9796
-$0.0404-3.96%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 23.43M | 17.11M | 15.49M | 12.17M | 4.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.56M | 46.21M | 42.45M | 36.04M | 8.84M |
| Operating Income | -53.56M | -46.21M | -42.45M | -36.04M | -8.84M |
| Income Before Tax | -13.73M | -7.92M | -5.94M | -18.46M | -60.48M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.73 | -7.92 | -5.94 | -18.46 | -60.48 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.73M | -7.92M | -5.94M | -18.46M | -60.48M |
| EBIT | -53.56M | -46.21M | -42.45M | -36.04M | -8.84M |
| EBITDA | -53.40M | -46.04M | -42.29M | -35.87M | -8.68M |
| EPS Basic | -0.09 | -0.14 | -0.14 | -0.29 | -0.62 |
| Normalized Basic EPS | -0.25 | -0.25 | -0.25 | -0.22 | -0.10 |
| EPS Diluted | -0.09 | -0.14 | -0.14 | -0.29 | -0.62 |
| Normalized Diluted EPS | -0.25 | -0.25 | -0.25 | -0.22 | -0.10 |
| Average Basic Shares Outstanding | 568.36M | 486.43M | 436.25M | 402.09M | 384.75M |
| Average Diluted Shares Outstanding | 568.36M | 486.43M | 436.25M | 402.09M | 384.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |